The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
|
---|---|
Published in |
Frontiers in Pharmacology, June 2022
|
DOI | 10.3389/fphar.2022.892240 |
Pubmed ID | |
Authors |
Tamás Ágh, Maja Ortner Hadžiabdić, Kristina Garuoliene, Anne Gerd Granas, Emma Aarnio, Enrica Menditto, João Gregório, Pilar Barnestein-Fonseca, Vildan Mevsim, Przemysław Kardas, European Network to Advance Best Practices and Technology on Medication Adherence |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Turkey | 1 | 25% |
Belgium | 1 | 25% |
Switzerland | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 27 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 4 | 15% |
Lecturer | 3 | 11% |
Student > Master | 2 | 7% |
Researcher | 2 | 7% |
Student > Ph. D. Student | 1 | 4% |
Other | 3 | 11% |
Unknown | 12 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 4 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
Nursing and Health Professions | 2 | 7% |
Business, Management and Accounting | 1 | 4% |
Agricultural and Biological Sciences | 1 | 4% |
Other | 4 | 15% |
Unknown | 13 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2022.
All research outputs
#12,603,998
of 22,792,160 outputs
Outputs from Frontiers in Pharmacology
#3,342
of 16,015 outputs
Outputs of similar age
#154,230
of 440,078 outputs
Outputs of similar age from Frontiers in Pharmacology
#145
of 1,191 outputs
Altmetric has tracked 22,792,160 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,015 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,078 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 1,191 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.